Review



recombinant type iv α5 collagen  (Aviva Systems)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Aviva Systems recombinant type iv α5 collagen
    Recombinant Type Iv α5 Collagen, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant type iv α5 collagen/product/Aviva Systems
    Average 92 stars, based on 1 article reviews
    recombinant type iv α5 collagen - by Bioz Stars, 2026-02
    92/100 stars

    Images



    Similar Products

    recombinant type iv α5 collagen  (Aviva Systems)
    92
    Aviva Systems recombinant type iv α5 collagen
    Recombinant Type Iv α5 Collagen, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant type iv α5 collagen/product/Aviva Systems
    Average 92 stars, based on 1 article reviews
    recombinant type iv α5 collagen - by Bioz Stars, 2026-02
    92/100 stars
    		  Buy from Supplier
    recombinant type iv (α5) collagen  (Aviva Systems)
    90
    Aviva Systems recombinant type iv (α5) collagen
    The graph shows the competitive inhibitions between Col3-4 peptide, standard of ELISA with the following derived peptides for binding to the ELISA antibody 1) extended Col3-4 peptide (Col3-4 peptide + 1 amino acid), 2) shortened Col3-4 peptide (Col3-4 peptide—1 amino acid), 3) non-hydroxylated Col3-4 peptide (Col3-4 non-hydroxylated peptide), 4) unrelated type III peptide (Col3(α1)-Col3-4 unrelated peptide), 5) homologous type IV <t>(α5)</t> collagen peptide (Col4(α5)-Col3-4 homologous peptide), 6) homologous type IX (α3) collagen peptide (Col9(α3)-Col3-4 homologous peptide), 7) homologous type IV (α1) collagen peptide (Col4(α1)-Col3-4 homologous peptide). The graph shows also the recognition of the antibody with intact type III (α1) collagen (Native Col3 (α1)) and type IV (α5) collagen <t>(Recombinant</t> Col4 (α5). Y-axis shows the relative binding of the antibody at different concentrations of each molecule (B) expressed as a percentage of the binding with no competitor peptide (B0). The x-axis shows the molar concentration of each peptide. In brackets are the immunoreactive peptides.
    Recombinant Type Iv (α5) Collagen, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant type iv (α5) collagen/product/Aviva Systems
    Average 90 stars, based on 1 article reviews
    recombinant type iv (α5) collagen - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    recombinant human α-subunits type iv collagen non-collagenous domain, α5(iv)nc1  (Cloud-Clone corp)
    90
    Cloud-Clone corp recombinant human α-subunits type iv collagen non-collagenous domain, α5(iv)nc1
    The graph shows the competitive inhibitions between Col3-4 peptide, standard of ELISA with the following derived peptides for binding to the ELISA antibody 1) extended Col3-4 peptide (Col3-4 peptide + 1 amino acid), 2) shortened Col3-4 peptide (Col3-4 peptide—1 amino acid), 3) non-hydroxylated Col3-4 peptide (Col3-4 non-hydroxylated peptide), 4) unrelated type III peptide (Col3(α1)-Col3-4 unrelated peptide), 5) homologous type IV <t>(α5)</t> collagen peptide (Col4(α5)-Col3-4 homologous peptide), 6) homologous type IX (α3) collagen peptide (Col9(α3)-Col3-4 homologous peptide), 7) homologous type IV (α1) collagen peptide (Col4(α1)-Col3-4 homologous peptide). The graph shows also the recognition of the antibody with intact type III (α1) collagen (Native Col3 (α1)) and type IV (α5) collagen <t>(Recombinant</t> Col4 (α5). Y-axis shows the relative binding of the antibody at different concentrations of each molecule (B) expressed as a percentage of the binding with no competitor peptide (B0). The x-axis shows the molar concentration of each peptide. In brackets are the immunoreactive peptides.
    Recombinant Human α Subunits Type Iv Collagen Non Collagenous Domain, α5(Iv)Nc1, supplied by Cloud-Clone corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human α-subunits type iv collagen non-collagenous domain, α5(iv)nc1/product/Cloud-Clone corp
    Average 90 stars, based on 1 article reviews
    recombinant human α-subunits type iv collagen non-collagenous domain, α5(iv)nc1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    The graph shows the competitive inhibitions between Col3-4 peptide, standard of ELISA with the following derived peptides for binding to the ELISA antibody 1) extended Col3-4 peptide (Col3-4 peptide + 1 amino acid), 2) shortened Col3-4 peptide (Col3-4 peptide—1 amino acid), 3) non-hydroxylated Col3-4 peptide (Col3-4 non-hydroxylated peptide), 4) unrelated type III peptide (Col3(α1)-Col3-4 unrelated peptide), 5) homologous type IV (α5) collagen peptide (Col4(α5)-Col3-4 homologous peptide), 6) homologous type IX (α3) collagen peptide (Col9(α3)-Col3-4 homologous peptide), 7) homologous type IV (α1) collagen peptide (Col4(α1)-Col3-4 homologous peptide). The graph shows also the recognition of the antibody with intact type III (α1) collagen (Native Col3 (α1)) and type IV (α5) collagen (Recombinant Col4 (α5). Y-axis shows the relative binding of the antibody at different concentrations of each molecule (B) expressed as a percentage of the binding with no competitor peptide (B0). The x-axis shows the molar concentration of each peptide. In brackets are the immunoreactive peptides.

    Journal: PLOS ONE

    Article Title: Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis

    doi: 10.1371/journal.pone.0282954

    Figure Lengend Snippet: The graph shows the competitive inhibitions between Col3-4 peptide, standard of ELISA with the following derived peptides for binding to the ELISA antibody 1) extended Col3-4 peptide (Col3-4 peptide + 1 amino acid), 2) shortened Col3-4 peptide (Col3-4 peptide—1 amino acid), 3) non-hydroxylated Col3-4 peptide (Col3-4 non-hydroxylated peptide), 4) unrelated type III peptide (Col3(α1)-Col3-4 unrelated peptide), 5) homologous type IV (α5) collagen peptide (Col4(α5)-Col3-4 homologous peptide), 6) homologous type IX (α3) collagen peptide (Col9(α3)-Col3-4 homologous peptide), 7) homologous type IV (α1) collagen peptide (Col4(α1)-Col3-4 homologous peptide). The graph shows also the recognition of the antibody with intact type III (α1) collagen (Native Col3 (α1)) and type IV (α5) collagen (Recombinant Col4 (α5). Y-axis shows the relative binding of the antibody at different concentrations of each molecule (B) expressed as a percentage of the binding with no competitor peptide (B0). The x-axis shows the molar concentration of each peptide. In brackets are the immunoreactive peptides.

    Article Snippet: Briefly, 200μg of native human type III collagen and 50μg of recombinant type IV (α5) collagen (Aviva Systems Biology Corporation, CA, US) were incubated in test-tubes for 48h at 37°C with 5μg of active human recombinant MMP-9 (Merck, Saint-Quentin-Fallavier, France) in MMP buffer.

    Techniques: Enzyme-linked Immunosorbent Assay, Derivative Assay, Binding Assay, Recombinant, Concentration Assay

    The graph shows the quantity of Col3-4 fragments measured by ELISA after incubation of human native type III collagen and recombinant type IV (α5) collagen with active recombinant human MMP-9 for 48h at 4°C. Results are shown as bars with mean ± SD of 2 independent experiments. 1) MMP buffer + MMP-9; 2) MMP buffer + native human type III collagen; 3) MMP buffer +MMP-9 + native human type III collagen; 4) MMP buffer + recombinant type IV(α5) collagen; 5) MMP buffer +MMP-9 + recombinant type IV(α5) collagen.

    Journal: PLOS ONE

    Article Title: Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis

    doi: 10.1371/journal.pone.0282954

    Figure Lengend Snippet: The graph shows the quantity of Col3-4 fragments measured by ELISA after incubation of human native type III collagen and recombinant type IV (α5) collagen with active recombinant human MMP-9 for 48h at 4°C. Results are shown as bars with mean ± SD of 2 independent experiments. 1) MMP buffer + MMP-9; 2) MMP buffer + native human type III collagen; 3) MMP buffer +MMP-9 + native human type III collagen; 4) MMP buffer + recombinant type IV(α5) collagen; 5) MMP buffer +MMP-9 + recombinant type IV(α5) collagen.

    Article Snippet: Briefly, 200μg of native human type III collagen and 50μg of recombinant type IV (α5) collagen (Aviva Systems Biology Corporation, CA, US) were incubated in test-tubes for 48h at 37°C with 5μg of active human recombinant MMP-9 (Merck, Saint-Quentin-Fallavier, France) in MMP buffer.

    Techniques: Enzyme-linked Immunosorbent Assay, Incubation, Recombinant